Republic of the Philippines Department of Health OFFICE OF THE SECRETARY ‘November 26, 2020 DEPARTMENT CIRCULAR No. 2020-_0388 DIRECTORS OF CENTERS FOR HEALTH DEVELOPMENT (CHD); DIVISION CHIEFS OF CHD-REGULATIONS, LICENSING AND ENFORCEMENT DIVISION (RLEDS) AND HEALTH FACILITIES AND SERVICES REGULATORY BUREAU; MINISTER OF HEALTH —— BANGSAMORO AUTONOMOUS REGION IN MUSLIM MINDANAO (MOH-BARMM); REGULATORY OFFICERS; HEAD OF CLINICAL LABORATORIES; AND ALL OTHERS CONCERNED FOR SUBJECT Surv inical toric Several clinical laboratory technological advancements were introduced through the years. As ‘such, it is imperative for the Department of Health (DOH) to revise and update some provisions in the current Administrative Order No. 2007-0027, titled “Revised Rules and Regulations Governing the Licensure and Regulation of Clinical Laboratories in the Philippines,” dated August 22, 2007. In line with this, the Health Facilities and Services Regulatory Bureau (HFSRB) and Center for Health Development ~ Regulations, Licensing and Enforcement Division (CHD-RLEDs) will conduct a survey to determine the actual current services being offered by the clinical laboratories ih the Philippines. Thus, all clinical laboratories, whether private or government owned and regardless of service capability, are enjoined to participate in this survey. The content of the survey can be found in Annex A, and responses will be submitted online via this link: https://tinyurl.com/DOH-Clinical-Laboratories on or before December 7, 2020. For further questions or details, please contact Ms. Frances Beltran or Mr. Rafael Mafigali at 8743- 8808 or 8651-7800 local 2525 or via email at hfsrb.sdd@gmail.com. For dissemination. By Authority of the Secretary of Health: DR. MARIA ROSARIO S. VERGEIRE, MPH, CESO IV OIC - Undersferetary of Health Health Regulation Team Bailing, Sen Tazo Compound, Real Avenue Sm Char 1005 Mania © Trak Line 51-700 eal Tow, TUTTE TT Dire Line: 71-9502; 711-903 Fax 743-1829 © URL: hvac doh ov ps e-mail Aqudedah gv phANNEX-A Region Name of the Facility Classification by institutional | Type of Molecular Diagnostic Character Machine/Equipment Government Free Standing Polymerase Chain Reaction Fluorescent in Situ Classification by Ownership Pivate ituton Based =o Sasaieaton Type Eelpment Used Norham Bing Primary aia Souther Bing Seon Arata aaa al octane Tertiary ‘Semi-Automated Others s Others Indicate the Tests Performed for Molecular Diagnostics ‘Services Offered jlucose ia Hemogicbn Mass Concentraten | Bog Glucose _[AF8-Smear (18 Microscopy) Hematoort/ Enthrecyle Volume | Oral Glucose Tolerance Test ; eae ara Wet Smear for Trichomonas White Blood Celis Count / Leukocyte Number HbAtc Aerobie Culture and Sensitivity Concentration Quantitative Platelet sian Blood Urea Nitrogen ‘Anaerobic Culture and Sensitivity Serologic Testing using Rapid Differential Count / Leukocyte Blood Ure Acid Test Kits ( Dengue, Hepatts 8, Type Number Fraction Syphilis, HIV) Machine-Based Serologic and Blood Typing (tube-metnod) | Blood Creatinine Immunological Testing including Tumor Markers Peripheral Blood Smear Total Cholesterol RP Coagulation Studies Tiglycerides ‘ASO Urine Pregnancy Test (kit) | High Density Lipoprotein (HOL) _| Pap Smear at Fecal Occult Blood (kit) Low Density Lipoprotein LDL) | Cytology i Urinalysis Electroivies Histopathology — Fecalysis / Stool Examination Gram Stain Immunohistochemistry ‘Microscopic Analysis of Other Body Fluid (Sperm, CSF, KOH Others ‘Synovial, Pericardi